Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 45

Sort by

Sort Order Select

Journal Articles

Thirty-Five Year Follow-up Analysis of Follicular Lymphoma Patients Treated through the Nebraska Lymphoma Study Group: Prognostic Factor Analysis and Outcomes

Amulya Yellala, MBBS, Elizabeth R. Lyden, MS, Heather Nutsch, Avyakta Kallam, MD, Kai Fu, MD PhD, Timothy C. Greiner, MS, MD, Philip Bierman, MD, Matthew A. Lunning, DO, FACP, R. Gregory Bociek, MD, James O. Armitage, MD, Julie M. Vose, MD MBA

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-142743

Published: 2020

Journal Articles

Adverse Prognostic Factors in Adult Secondary Hemophagocytic Lymphohistiocytosis: Results from Two Tertiary Academic Centers

Omar Abughanimeh, MD, Ayman Qasrawi, MD, James O. Armitage, MD, Julie M. Vose, MD MBA, Gerhard C. Hildebrandt, MD, Muhamed Baljevic, MD

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-137038

Published: 2020

Journal Articles

Effect of Using Multiagent Versus Single Agent Chemotherapy on Overall Survival (OS) of Older Adults with Acute Myeloid Leukemia (AML)

Vijaya R. Bhatt, MD, Valerie K Shostrom, Sarah A. Holstein, MD PhD, Zaid S. Al-Kadhimi, MD, Lori J. Maness, MD, Ann Berger, PhD APRN-CNS, AOCNS, FAAN, James O. Armitage, MD, Krishna Gundabolu, MBBS

Blood (2019) 134 (Supplement_1): 2155.

https://doi.org/10.1182/blood-2019-122679

Published: 2019

Journal Articles

The Effect of Age and CD34+ Stem Cell Dose on Autologous Hematopoietic Stem Cell Transplantation Outcomes in Multiple Myeloma - Single Institution Experience

Madeline Skousen, Sarah A. Holstein, MD PhD, Matthew A. Lunning, DO, FACP, Elizabeth R. Lyden, MS, Gilmore Sheree, BA, Kimberly Schmit-Pokorny, Nurse Manager, James O. Armitage, MD, Zaid S. Al-Kadhimi, MD, Julie M Vose, MDMBA, Muhamed Baljevic, MD

Blood (2019) 134 (Supplement_1): 2028.

https://doi.org/10.1182/blood-2019-131594

Published: 2019

Journal Articles

Integrating Geriatric Assessment and Genetic Profiling to Personalize Therapy Selection in Older Adults with Acute Myeloid Leukemia (AML)

Vijaya R. Bhatt, MD, Christopher Wichman, PhD, Zaid S. Al-Kadhimi, MD, Thuy T. Koll, MD, Ann Berger, PhD APRN-CNS, AOCNS, FAAN, James O. Armitage, MD, Sarah A. Holstein, MD PhD, Krishna Gundabolu, MBBS, Lori J. Maness, MD

Blood (2019) 134 (Supplement_1): 120.

https://doi.org/10.1182/blood-2019-124375

Published: 2019

Journal Articles

A Single-Center Phase IIa Study Evaluating the Safety and Tolerability of Umbralisib and Ibrutinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Matthew A. Lunning, DO, Philip Bierman, MD, R. Gregory Bociek, MD, James O. Armitage, MD, Peggy Heires, R.N., Maribeth Hohenstein, R.N, Susan Blumel, RN, Jonathan Tefft, B.A., Elizabeth R. Lyden, MS, Michael R Green, PhD, Julie M. Vose, MD MBA

Blood (2018) 132 (Supplement 1): 5390.

https://doi.org/10.1182/blood-2018-99-119765

Published: 2018

Journal Articles

Academic Centers Are Associated with Improved Survival Outcomes in High Risk Diffuse Large B-Cell Lymphoma Patients

Daniel A. Ermann, MD, Victoria Vardell Noble, Avyakta Kallam, MBBS, James O. Armitage, MD

Blood (2018) 132 (Supplement 1): 4747.

https://doi.org/10.1182/blood-2018-99-115578

Published: 2018

Journal Articles

Allogeneic Stem Cell Transplantation for Multiple Myeloma: A 34-Year Experience

Courtney Venegas, BA, Matthew A. Lunning, DO, Zaid S. Al-Kadhimi, MD, Vijaya R. Bhatt, MD, Elizabeth R. Lyden, MS, Kimberly Schmit-Pokorny, Nurse Manager, James O. Armitage, MD, Julie M. Vose, MD MBA, Sarah A. Holstein, MD PhD, Muhamed Baljevic, MD

Blood (2018) 132 (Supplement 1): 5780.

https://doi.org/10.1182/blood-2018-99-116990

Published: 2018

Journal Articles

The Association between CD34+ Dose, Platelet Recovery and Incidence of Relapse after Autologous Stem Cell Transplant in Multiple Myeloma

Muhamed Baljevic, MD, Sarah A. Holstein, MD PhD, Matthew A. Lunning, DO, Elizabeth R. Lyden, MS, James O. Armitage, MD, Julie M. Vose, MDMBA

Blood (2017) 130 (Supplement 1): 3287.

https://doi.org/10.1182/blood.V130.Suppl_1.3287.3287

Published: 2017

Journal Articles

Systemic ALK-Positive Anaplastic Large-Cell Lymphoma (ALCL): Final Analysis of an International, Individual Patient Data Study of 263 Adults

David Sibon, MD PhD, Dinh-Phong Nguyen, MD, Norbert Schmitz, MD, Ritsuro Suzuki, MD PhD, Andrew L Feldman, MD, Remy Gressin, MD, Laurence Lamant, MD PhD, Dennis D. Weisenburger, MD, Shigeo Nakamura, MD PhD, Marita Ziepert, PhD, Matthew J Maurer, MS, Martin Bast, James O. Armitage, MD, Julie M. Vose, MDMBA, Herve Tilly, Jean-Philippe Jais, MD PhD, Kerry J Savage, MD

Blood (2017) 130 (Supplement 1): 1514.

https://doi.org/10.1182/blood.V130.Suppl_1.1514.1514

Published: 2017

Journal Articles

Center Effect and Socioeconomic Determinants of Overall Survival (OS) of Diffuse Large B Cell Lymphoma (DLBCL)

Avyakta Kallam, MBBS, James O. Armitage, MD, Baojiang Chen, PhD, Julie M. Vose, MD, Vijaya R. Bhatt, MD

Blood (2016) 128 (22): 5949.

https://doi.org/10.1182/blood.V128.22.5949.5949

Published: 2016

Journal Articles

Safety and Efficacy of Enoxaparin Prophylaxis in Adults Receiving Peg-Asparaginase Containing Induction Regimens for Acute Lymphoblastic Leukemia (ALL)

Jayadev Manikkam Umakanthan, MBBS, Lori J. Maness, MD, Jiangtao Luo, Avyakta Kallam, MBBS, James O. Armitage, MD, Philip Bierman, MD, Julie M. Vose, MD, R. Gregory Bociek, MD, Matthew Lunning, DO, Krishna Gundabolu, MD, Vijaya R. Bhatt, MD

Blood (2016) 128 (22): 5154.

https://doi.org/10.1182/blood.V128.22.5154.5154

Published: 2016

Journal Articles

Risk of 30-Day Mortality and Its Association with Health System and Socioeconomic Factors in Diffuse Large B Cell Lymphoma (DLBCL)

Avyakta Kallam, MBBS, Julie M Vose, MD, Baojiang Chen, PhD, James O. Armitage, MD, Vijaya R. Bhatt, MD

Blood (2016) 128 (22): 2347.

https://doi.org/10.1182/blood.V128.22.2347.2347

Published: 2016

Journal Articles

National Trend in Splenectomy for Splenic Marginal Zone Lymphoma (SMZL): An Analysis of Surveillance, Epidemiology and End Results (SEER) Database

Smith Giri, MBBS, Vijaya R. Bhatt, MD, Ranjan Pathak, MD, R. Gregory Bociek, MD, James O. Armitage, MD

Blood (2015) 126 (23): 5630.

https://doi.org/10.1182/blood.V126.23.5630.5630

Published: 2015

Journal Articles

Clinical Impact of Internet-Based Tools to Help Guide Therapeutic Decisions for Mantle Cell Lymphoma (MCL)

Kristen M Rosenthal, PhD, Christopher R. Flowers, MD, Andre Goy, MD, John P. Leonard, MD, Julie M. Vose, MD, Erik D. Brady, PhD CHCP, Jim Mortimer, Kevin L Obholz, PhD, James O. Armitage, MD

Blood (2015) 126 (23): 4527.

https://doi.org/10.1182/blood.V126.23.4527.4527

Published: 2015

Journal Articles

Use of Low Molecular Weight Heparin (LMWH) in Thrombocytopenic Patients with Hematologic Malignancy-Associated Venous Thromboembolism (VTE)

Nabin Khanal, MBBS, R. Gregory Bociek, MD, Baojiang Chen, PhD, Julie M. Vose, MD, James O. Armitage, MD, Philip J Bierman, MD, Lori J. Maness, MD, Matthew A. Lunning, DO, Krishna Gundabolu, MD, Vijaya R. Bhatt, MD

Blood (2015) 126 (23): 3482.

https://doi.org/10.1182/blood.V126.23.3482.3482

Published: 2015

Journal Articles

Classification of Non-Hodgkin Lymphoma in Seven Geographic Regions Around the World: Review of 4539 Cases from the International Non-Hodgkin Lymphoma Classification Project

Anamarija M. Perry, MD, Diebold Jacques, MD, Bharat N. Nathwani, MD, Kenneth Angus Maclennan, MD, H Konrad Müller-Hermelink, Eugene Boilesen, Martin Bast, BS, James O. Armitage, MD, Dennis D. Weisenburger, MD

Blood (2015) 126 (23): 1484.

https://doi.org/10.1182/blood.V126.23.1484.1484

Published: 2015

Journal Articles

Tolerability and Efficacy of Treatments in Elderly Patients with Hodgkin Lymphoma: A Report from the Nebraska Lymphoma Study Group

Roberto A. Ferro, MD, Vijaya R. Bhatt, MD, Martin Bast, BS, Lynette Smith, MS, R. Gregory Bociek, MD, Matthew A. Lunning, DO, Philip J Bierman, MD, Julie M. Vose, MD, James O. Armitage, MD

Blood (2015) 126 (23): 1504.

https://doi.org/10.1182/blood.V126.23.1504.1504

Published: 2015

Journal Articles

Clinicopathologic Features, Management and Outcomes of Blastoid Variant (BV) of Mantle Cell Lymphoma (MCL): A Nebraska Lymphoma Study Group (NLSG) Experience

Vijaya R. Bhatt, MBBS, Fausto R. Loberiza, MD MS, James O. Armitage, MD, Timothy C. Greiner, MS, MD, Martin Bast, BS, Matthew A. Lunning, DO, Philip Bierman, MD, Julie M. Vose, MD MBA, R. Gregory Bociek, MD MSc.

Blood (2014) 124 (21): 2971.

https://doi.org/10.1182/blood.V124.21.2971.2971

Published: 2014

Journal Articles

Cell Of Origin Does Not Affect Outcomes In Early Stage Non-Bulky Diffuse Large B-Cell Lymphoma Treated With Short-Course Combined Modality Therapy

Matthew A. Lunning, DO, Jocelyn C. Maragulia, BS, Anita Kumar, MD, Martin Bast, BS, Philip Bierman, MD, R. Gregory Bociek, MD, Julie M Vose, MD, MBA, James O. Armitage, MD, Steven M. Horwitz, MD, Andrew D Zelenetz, MD, PhD

Blood (2013) 122 (21): 3017.

https://doi.org/10.1182/blood.V122.21.3017.3017

Published: 2013

NARROW

Thirty-Five Year Follow-up Analysis of Follicular Lymphoma Patients Treated through the Nebraska Lymphoma Study Group: Prognostic Factor Analysis and Outcomes

Adverse Prognostic Factors in Adult Secondary Hemophagocytic Lymphohistiocytosis: Results from Two Tertiary Academic Centers

Effect of Using Multiagent Versus Single Agent Chemotherapy on Overall Survival (OS) of Older Adults with Acute Myeloid Leukemia (AML)

The Effect of Age and CD34+ Stem Cell Dose on Autologous Hematopoietic Stem Cell Transplantation Outcomes in Multiple Myeloma - Single Institution Experience

Integrating Geriatric Assessment and Genetic Profiling to Personalize Therapy Selection in Older Adults with Acute Myeloid Leukemia (AML)

A Single-Center Phase IIa Study Evaluating the Safety and Tolerability of Umbralisib and Ibrutinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Academic Centers Are Associated with Improved Survival Outcomes in High Risk Diffuse Large B-Cell Lymphoma Patients

Allogeneic Stem Cell Transplantation for Multiple Myeloma: A 34-Year Experience

The Association between CD34+ Dose, Platelet Recovery and Incidence of Relapse after Autologous Stem Cell Transplant in Multiple Myeloma

Systemic ALK-Positive Anaplastic Large-Cell Lymphoma (ALCL): Final Analysis of an International, Individual Patient Data Study of 263 Adults

Center Effect and Socioeconomic Determinants of Overall Survival (OS) of Diffuse Large B Cell Lymphoma (DLBCL)

Safety and Efficacy of Enoxaparin Prophylaxis in Adults Receiving Peg-Asparaginase Containing Induction Regimens for Acute Lymphoblastic Leukemia (ALL)

Risk of 30-Day Mortality and Its Association with Health System and Socioeconomic Factors in Diffuse Large B Cell Lymphoma (DLBCL)

National Trend in Splenectomy for Splenic Marginal Zone Lymphoma (SMZL): An Analysis of Surveillance, Epidemiology and End Results (SEER) Database

Clinical Impact of Internet-Based Tools to Help Guide Therapeutic Decisions for Mantle Cell Lymphoma (MCL)

Use of Low Molecular Weight Heparin (LMWH) in Thrombocytopenic Patients with Hematologic Malignancy-Associated Venous Thromboembolism (VTE)

Classification of Non-Hodgkin Lymphoma in Seven Geographic Regions Around the World: Review of 4539 Cases from the International Non-Hodgkin Lymphoma Classification Project

Tolerability and Efficacy of Treatments in Elderly Patients with Hodgkin Lymphoma: A Report from the Nebraska Lymphoma Study Group

Clinicopathologic Features, Management and Outcomes of Blastoid Variant (BV) of Mantle Cell Lymphoma (MCL): A Nebraska Lymphoma Study Group (NLSG) Experience

Cell Of Origin Does Not Affect Outcomes In Early Stage Non-Bulky Diffuse Large B-Cell Lymphoma Treated With Short-Course Combined Modality Therapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only